Recro Pharma Inc. (REPH)
NASDAQ: REPH
· Real-Time Price · USD
2.09
-0.01 (-0.48%)
At close: Mar 22, 2022, 5:00 AM
Recro Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 579K | n/a | -4.68M | -9.17M | -3.33M | -3.12M | -4.26M | -2.36M | -3.49M | 1.23M | -6.76M |
Depreciation & Amortization | 4.7M | n/a | 2.09M | 2.12M | 2.17M | 2.02M | 2.01M | 1.93M | 1.91M | 1.65M | 2.08M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -9.18M | n/a | 1.37M | 7.81M | 1.46M | 1.79M | -4.83M | 883K | 3.39M | -629K | 446K |
Other Non-Cash Items | -1.95M | n/a | -4K | 221K | n/a | n/a | 1.26M | 1.28M | 1.45M | -1.73M | 1.46M |
Deferred Income Tax | -998K | n/a | 72K | 1.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -5.16M | n/a | -1.37M | 6.53M | 376K | 1.66M | -8.56M | 3.45M | 2.49M | -256K | -5K |
Operating Cash Flow | -146K | n/a | -2.85M | 1.99M | 473K | 1.97M | -8.08M | 4.44M | 3.68M | 2.82M | -89K |
Capital Expenditures | -2.13M | n/a | -3.38M | -2.74M | -2.31M | -1.6M | -1.71M | -2.52M | -653K | -635K | -1.48M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 24.01M | -24.01M | n/a | n/a |
Investing Cash Flow | -2.13M | n/a | -3.38M | -2.74M | -2.31M | -1.6M | -1.71M | -2.52M | -24.66M | -635K | -1.48M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -101K | n/a | n/a | 101K | n/a | n/a | -101K | -196K | -93K | -126K | -336K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 655K | n/a | -2.47M | 4.16M | -2.07M | -166K | -153K | -196K | -1.25M | 31.98M | -10.64M |
Financial Cash Flow | 655K | n/a | -2.47M | 4.16M | -2.07M | -166K | -153K | -196K | -1.25M | 31.98M | -10.64M |
Net Cash Flow | -1.62M | n/a | -8.7M | 3.42M | -3.9M | 205K | -9.94M | 1.73M | -22.23M | 34.17M | -12.2M |
Free Cash Flow | -2.27M | n/a | -6.23M | -742K | -1.84M | 371K | -9.79M | 1.92M | 3.03M | 2.19M | -1.57M |